SELLAS Life Sciences Group Inc (SLS)
1.53
-0.01
(-0.65%)
USD |
NASDAQ |
Apr 25, 12:52
SELLAS Life Sciences Group Total Liabilities (Quarterly): 14.20M for Dec. 31, 2023
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
Date | Value |
---|---|
December 31, 2023 | 14.20M |
September 30, 2023 | 11.91M |
June 30, 2023 | 13.72M |
March 31, 2023 | 15.94M |
December 31, 2022 | 16.09M |
September 30, 2022 | 13.40M |
June 30, 2022 | 13.15M |
March 31, 2022 | 17.41M |
December 31, 2021 | 5.928M |
September 30, 2021 | 11.34M |
June 30, 2021 | 10.21M |
March 31, 2021 | 11.83M |
December 31, 2020 | 18.09M |
September 30, 2020 | 10.56M |
June 30, 2020 | 10.73M |
March 31, 2020 | 8.964M |
December 31, 2019 | 10.52M |
September 30, 2019 | 10.85M |
June 30, 2019 | 10.70M |
March 31, 2019 | 11.98M |
December 31, 2018 | 11.67M |
September 30, 2018 | 20.01M |
June 30, 2018 | 34.46M |
March 31, 2018 | 34.80M |
December 31, 2017 | 31.46M |
Date | Value |
---|---|
September 30, 2017 | 34.96M |
June 30, 2017 | 41.43M |
March 31, 2017 | 43.14M |
December 31, 2016 | 11.42M |
September 30, 2016 | 48.92M |
June 30, 2016 | 53.46M |
March 31, 2016 | 53.95M |
December 31, 2015 | 68.63M |
September 30, 2015 | 50.25M |
June 30, 2015 | 52.60M |
March 31, 2015 | 49.52M |
December 31, 2014 | 43.43M |
September 30, 2014 | 48.63M |
June 30, 2014 | 51.96M |
March 31, 2014 | 45.79M |
December 31, 2013 | 82.09M |
September 30, 2013 | 56.63M |
June 30, 2013 | 46.77M |
March 31, 2013 | 38.14M |
December 31, 2012 | 27.23M |
September 30, 2012 | 21.03M |
June 30, 2012 | 19.84M |
March 31, 2012 | 38.78M |
December 31, 2011 | 20.86M |
September 30, 2011 | 25.62M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
5.928M
Minimum
Dec 2021
18.09M
Maximum
Dec 2020
12.40M
Average
11.83M
Median
Mar 2021
Total Liabilities (Quarterly) Benchmarks
Geron Corp | 146.13M |
Immuneering Corp | 12.01M |
Protagonist Therapeutics Inc | 21.27M |
Akebia Therapeutics Inc | 272.29M |
Moderna Inc | 4.572B |
Total Liabilities (Quarterly) Related Metrics
Total Assets (Quarterly) | 6.219M |
Shareholders Equity (Quarterly) | -7.976M |